Biotechnology: Pharmaceutical Preparations

OtherApr 29, 2026, 06:13 AM

ADXN Files 6-K, Attaches April 29 Press Release

AI Summary

Addex Therapeutics Ltd. filed a Form 6-K with the SEC on April 29, 2026. This filing announced the issuance of a press release on the same date, which is attached as Exhibit 99.1 and incorporated by reference into the company's registration statements. The 6-K itself did not detail the content of the press release.

Key Highlights

Addex Therapeutics filed a Form 6-K with the SEC on April 29, 2026.
The filing incorporated by reference a press release dated April 29, 2026, as Exhibit 99.1.

View SEC Filing

ADXN

Biotechnology: Pharmaceutical Preparations

Addex Therapeutics Ltd.

Price Impact